Vesugen
Vesugen
A synthetic tripeptide that supports vascular health and endothelial function. Part of the Russian peptide bioregulator family.
Typical Cost
$50-100/vial
Status
Research
Peptide Profile
Vesugen
Mechanism of Action
Supports endothelial cell function and vascular health. Improves microcirculation and blood vessel elasticity. May support cardiovascular health through vascular optimization.
Common Dosages
oral
1-2mg
Daily · 4-6 weeks
Benefits
Improved vascular function
Better microcirculation
Endothelial support
Cardiovascular health
Side Effects
Limited data
Generally well-tolerated
Key Research
Vesugen and vascular health
Demonstrated improvements in endothelial function and microcirculation
Regulatory Status
Research chemical. Russian development. Not FDA-approved.
Contraindications
- ⚠Pregnancy/breastfeeding
- ⚠Bleeding disorders
GLP-1 users focused on cardiovascular health may consider vesugen alongside SeraVia formulations.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.